DOI: 10.4244/EIJV13I17A326

May in Paris! Join us! EuroPCR 2018

Michael Haude, MD, President EAPCI

With the year progressing quickly and May soon upon us, I want to take this opportunity to invite you all – if you haven’t made your plans already – to join us at the official scientific meeting of the EAPCI, EuroPCR, which will be taking place at the Palais des Congrès in Paris from 22 to 25 May.

There is little to add that is not already universally acknowledged about this dynamic and trend-setting Course. It has become an indispensable annual rendezvous for all our profession, a point in time and space when all the different aspects and concerns of our speciality intersect, a privileged moment openly and freely to exchange with our peers the latest news and, more importantly, the latest insights into how we practise interventional medicine today. EuroPCR is the theatre for a vast number of activities that take place each year – from the annual meeting of our association (this year witnessing the changing of Presidents, but more about that next month) to the training sessions and hands-on demonstrations of technique, to the live case broadcasts from leading centres throughout the world… I could go on, but I think we are all aware of the dimensions of the official scientific meeting of our association and why we should all participate.

The Course is never a static affair and each year holds its special surprises. Some are due to evolutions in our devices, or insights into the care we offer or the healthcare systems in which we work. Others reflect our expanding knowledge in such topics as valvular therapy or ischaemic stroke or, as last year, an opportunity to explore the history of our profession.

In 2017, we didn’t just celebrate the 40 years of PCI, but began what we feel is a major evolution in the type of education we offer to Fellows. At the initiative of the EAPCI’s New Initiatives For Young Interventionists Committee, the EAPCI Fellows Course, which had previously taken place outside of the EuroPCR meeting, became an integral part of EuroPCR itself. This change in timing and the subsequent integration within the meeting brought with it numerous possibilities, allowing specially focused sessions designed by and for the young specialists and permitting us to highlight which sessions and symposiums during the main programme were relevant for these Fellows.

We must never forget that our ultimate goal in improving medical care for all requires the highest level of education, outreach and the ability to create – and sustain – communities. To do this, we need to have a high level of coordination, confidence and trust among all the different players involved in providing healthcare today. Nurses and allied health professionals, engineers developing new and innovative devices, government regulatory bodies and national societies along with our industry partners all play a concerted part in the success of the whole.

One of the aspects that makes a Course such as EuroPCR accessible and sustainable is financing. An example of this can be seen in the activities of the Fellows Course which received generous educational grants provided by industry sponsors. This year, independent funding by industry has evolved, becoming more transparent and continuing as an ethical process. MedTech Europe, the official trade association that represents the European medical technology industry remains “fully committed to support independent medical education” and has developed a code of practice, which took effect on 1 January to govern their relationship to CME, allowing them to “safeguard and protect” their “relationship with healthcare professionals by adopting a clear and strict self-regulation… through independent third-parties”. EuroPCR and the EAPCI are such parties, and are pleased to continue in our traditional role of providing information – and education – to any and all of our members.

Working together, the EAPCI is proud of the success and evolution of EuroPCR and the quality of the education we can offer. The success of individual aspects of our work, like the Fellows programme, underlines what we can accomplish by committing ourselves to a free exchange of experience and ideas. The actions of our association and the work of the Course support the sharing of clinical knowledge, provide a foundation for innovation and offer opportunities for advancement in the practice of our speciality for all those wishing to participate – whether a student, a young fellow beginning their professional career, or the more accomplished specialists and healthcare providers among us.

Volume 13 Number 17
Apr 20, 2018
Volume 13 Number 17
View full issue


Key metrics

On the same subject

10.4244/EIJV13I4A61 Jul 20, 2017
Working together today for the future: the EAPCI general assembly 2017
Haude M
free

Editorial

10.4244/EIJ-E-23-00027 May 12, 2023
Continuously renewing and at the cutting edge: Welcome to EuroPCR 2023!
Cuisset T et al
free

10.4244/EIJV15I5A74 Aug 29, 2019
Working across borders: EAPCI and the National Societies
Baumbach A
free

10.4244/EIJV15I1A7 May 20, 2019
The year ahead: EAPCI milestones
Baumbach A
free

10.4244/EIJV14I13A247 Jan 18, 2019
Interventional cardiologists: the next generation
Baumbach A
free

10.4244/EIJV13I13A243 Jan 19, 2018
Answering the challenges of the New Year – the EAPCI in 2018
Haude M
free
Trending articles
338.03

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
284.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved